MICHIGAN MOLECULAR INSTITUTE – Trademark Portfolio
Entity Type: 03
MICHIGAN MOLECULAR INSTITUTE holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 1 (Chemicals) — 3 filings in this category. The portfolio also extends into Class 42 (Computer & Scientific) across 3 Nice Classification classes. Currently, 3 trademarks are registered. Notable registered marks include DENDRITECH and IMPACT ANALYTICAL. The owner is based in Midland, MI.
1910 W. St. Andrews Road
Midland, MI 48640
Showing of trademarks Trademarks
Trademark Classifications
MICHIGAN MOLECULAR INSTITUTE's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Chemical products for industry, science, photography, agriculture, horticulture and forestry
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does MICHIGAN MOLECULAR INSTITUTE have?
MICHIGAN MOLECULAR INSTITUTE has 6 U.S. trademarks filed with the USPTO. Of these, 3 registered, 1 abandoned, 2 cancelled.
What trademark classes does MICHIGAN MOLECULAR INSTITUTE file in?
MICHIGAN MOLECULAR INSTITUTE files trademarks across 3 Nice Classification classes. The most active classes are Class 1 (Chemicals), Class 42 (Computer & Scientific), Class 40 (Treatment & Processing). Class 1 covers chemical products for industry, science, photography, agriculture, horticulture and forestry.
What are MICHIGAN MOLECULAR INSTITUTE's most well-known trademarks?
MICHIGAN MOLECULAR INSTITUTE's registered trademark portfolio includes well-known marks such as DENDRITECH and IMPACT ANALYTICAL. These are among 3 currently registered trademarks in the portfolio.
What is MICHIGAN MOLECULAR INSTITUTE's trademark registration success rate?
MICHIGAN MOLECULAR INSTITUTE has a 50% trademark registration rate, with 3 out of 6 resolved applications resulting in successful registration. Currently, 0 applications are pending review.